Skip to main content
OpenTrials

Clinical trial condition

Infection, Human Immunodeficiency Virus

Explore clinical trials studying Infection, Human Immunodeficiency Virus. Study availability and eligibility vary by location and protocol.

107 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Infection, Human Immunodeficiency Virus trial results

Completed

Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection

NCT02178592

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Coinfection, +15 more
Locations
  • GSK Investigational Site Ciudad de Buenos Aires, Buenos Aires, Argentina
  • GSK Investigational Site Rosario, Santa Fe Province, Argentina
  • GSK Investigational Site Manaus, Amazonas, Brazil
  • GSK Investigational Site Salvador, Estado de Bahia, Brazil
View all 28 locations
View Trial Details
Completed

Dolutegravir Expanded Access Study

NCT01536873

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Fort Lauderdale, Florida, United States
View all 74 locations
View Trial Details
Completed

Incidence of Human Immunodeficiency Virus-1 (HIV-1) Infection in HIV-1 Uninfected High Risk Men Who Have Sex With Men

NCT03310515

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Shenyang, Liaoning, China
  • GSK Investigational Site Chengdu, Sichuan, China
  • GSK Investigational Site Hangzhou, Zhejiang, China
View Trial Details
Completed

Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults

NCT03045861

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 14 locations
View Trial Details

Related conditions